1999
DOI: 10.1007/s002109900054
|View full text |Cite
|
Sign up to set email alerts
|

Inhibitory effect of cannabinoid agonists on gastric emptying in the rat

Abstract: We have studied the effect of WIN 55,212-2 (a psychoactive cannabinoid agonist), cannabinol (a nonpsychoactive cannabinoid agonist), SR141716A, a cannabinoid CB1 antagonist, and SR144528, a cannabinoid CB2 antagonist, on gastric emptying in the rat. WIN 55,212-2 (0.1-5 mg/kg, i.p.) and cannabinol (0.1-25 mg/kg, i.p.) dose-dependently delayed gastric emptying while SR141716A (1 mg/kg and 5 mg/kg) and SR144528 (1 mg/kg) were without effect. SR141716A (1 mg/kg), but not SR144528 (1 mg/kg), counteracted the inhibi… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

8
73
3
2

Year Published

2002
2002
2023
2023

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 110 publications
(87 citation statements)
references
References 12 publications
(23 reference statements)
8
73
3
2
Order By: Relevance
“…Cannabinoids were shown to inhibit gastrointestinal motility (Izzo et al, 1999;Krowicki et al, 1999), gastric acid secretion (Adami et al, 2002) and development of gastric mucosal lesions both in acid-dependent (Germano et al, 2001;Rutkowska and Fereniec-Goltbiewska, 2006) and acid-independent ulcer models (Shujaa et al, 2009). Accordingly, CB 1 receptors were identified in neurons of the enteric nervous system and in sensory terminals of vagal and spinal neurons, moreover, CB 1 receptors are also identified in the dorsal vagal complex: in the nucleus of the solitary tract (NTS) (Partosoedarso et al, 2003), in the dorsal motor nucleus of vagus (DMNV) (Mackie, 2005) and prominently, in the area postrema (Mackie, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…Cannabinoids were shown to inhibit gastrointestinal motility (Izzo et al, 1999;Krowicki et al, 1999), gastric acid secretion (Adami et al, 2002) and development of gastric mucosal lesions both in acid-dependent (Germano et al, 2001;Rutkowska and Fereniec-Goltbiewska, 2006) and acid-independent ulcer models (Shujaa et al, 2009). Accordingly, CB 1 receptors were identified in neurons of the enteric nervous system and in sensory terminals of vagal and spinal neurons, moreover, CB 1 receptors are also identified in the dorsal vagal complex: in the nucleus of the solitary tract (NTS) (Partosoedarso et al, 2003), in the dorsal motor nucleus of vagus (DMNV) (Mackie, 2005) and prominently, in the area postrema (Mackie, 2005).…”
Section: Introductionmentioning
confidence: 99%
“…An inhibitory action on intestinal transit, as elicited by the ethyl acetate fraction in this study, delays the passage of gastrointestinal contents and allows feces to become desiccated, thus further retarding movement through the colon (Akindede & Adeyemi, 2006). The effect of C. lutea in reducing intestinal propulsion is linked to delay in gastric emptying, as observed for the case with atropine and morphine (Izzo et al, 1999;Akindele & Adeyemi, 2006). The dose 770 mg/ kg of ethyl acetate fraction inducing 100% inhibition of IPM is critical as other doses (median or lower) did not produce significant dose-dependent inhibition of gastric emptying (unpublished data).…”
Section: Discussionmentioning
confidence: 59%
“…One mL of the marker (10% charcoal suspension in 5% gum acacia) was administered orally 1 hour after castor oil treatment. The rats were sacrificed after 1 hour and the distance traveled by the charcoal meal from the pylorus was measured and expressed as the percentage of the total length of the intestine from the pylorus to cecum (Izzo et al, 1999).…”
Section: Small Intestinal Transitmentioning
confidence: 99%